
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
74.65 US$
+1.32 US$ · +1.80%
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
الإغلاق السابق
74.65 US$
+1.32 US$ · +1.80%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
نطاق اليوم
السعر الحالي 74.65 US$
نطاق 52 أسبوعًا
السعر الحالي 74.65 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
86
قيمة جذابة جدًا
المشاعر
79
صعودي
المخاطر
43
مخاطر أعلى من المعتاد
الزخم
37
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
نطاق اليوم
السعر الحالي 74.65 US$
نطاق 52 أسبوعًا
السعر الحالي 74.65 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 2.94 مليار USD | 2.52 مليار USD | 1.57 مليار USD | 1.02 مليار USD | 958.1 مليون USD |
| تكلفة البضاعة المباعة | 957.8 مليون USD | 1.04 مليار USD | 548.17 مليون USD | 263.73 مليون USD | 239.22 مليون USD |
| الربح الإجمالي | 1.98 مليار USD | 1.48 مليار USD | 1.02 مليار USD | 759.12 مليون USD | 718.88 مليون USD |
| البحث والتطوير | 185 مليون USD | 163.75 مليون USD | 124.01 مليون USD | 73.02 مليون USD | 97.35 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 1.32 مليار USD | 981.05 مليون USD | 643.41 مليون USD | 432.12 مليون USD | 408.15 مليون USD |
| نفقات التشغيل | 1.5 مليار USD | 1.32 مليار USD | 887.16 مليون USD | 531.17 مليون USD | 546.93 مليون USD |
| دخل الفوائد | 7.14 مليون USD | — | 20.13 مليون USD | 14.23 مليون USD | 9.3 مليون USD |
| مصاريف الفوائد | — | 4.19 مليون USD | — | — | — |
| الاستهلاك والإطفاء | 276.84 مليون USD | 254.02 مليون USD | 144.73 مليون USD | 68.25 مليون USD | 69.87 مليون USD |
| الدخل التشغيلي | 479.8 مليون USD | 165.99 مليون USD | 133.14 مليون USD | 227.95 مليون USD | 171.95 مليون USD |
| صافي الدخل | 537.9 مليون USD | 102.98 مليون USD | 122.87 مليون USD | 190.17 مليون USD | 149.19 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
95.13 US$
ارتفاع محتمل بنسبة 27.43%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI292.44 مليون0.01%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Morningstar Small-Cap ETFVB211.96 مليون0.11%185.3 مليار USD0.03%289.48 US$+0.64%
Vanguard Morningstar Small-Cap Growth ETFVBK121.72 مليون0.27%44.7 مليار USD0.05%344.74 US$+1.22%
Vanguard Extended Market ETFVXF107.12 مليون0.11%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Targeted Value ETFDFAT79.09 مليون0.26%30.12 مليار USD0.33%67.27 US$-0.43%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY61.48 مليون0.24%25.82 مليار USD0.23%669.87 US$+0.54%
Dimensional - US Small Cap ETFDFAS44.93 مليون0.13%33.87 مليار USD0.31%78.35 US$+0.32%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD43.88 مليون0.24%18.27 مليار USD0.03%64.33 US$+0.56%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Growth ETFVBK
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFAT
State Street SPDR S&P MIDCAP 400 ETF TrustMDY
Dimensional - US Small Cap ETFDFAS
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMDالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.